Datascension, Inc.
145 S. State College Blvd., Suite 350
Brea, California, 92821
Tel : (714) 482-9750
Fax : (714) 482-9751

January 30, 2006

TO:

MR. MICHAEL MCTIERNAN, STAFF ATTORNEY
Tel: (202) 824-5445
Fax: (202) 942-9635

Securities Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W., Mail Stop 4561
Washington, D.C. 20549

RE:    DATASCENSION, INC.
       AMENDMENT NO. 4 TO REGISTRATION STATEMENT ON FORM SB-2
       FILED October 7, 2005
       REGISTRATION NO. 333-121851

Dear Mr. McTiernan,

Here follows our responses to your comment letter dated October 26, 2005.


Summary Financial Information, page 16

   1.  Please  recalculate  your basic and diluted net income per share amounts
       for the year ended December  31,  2003  to  reflect the restatement.  In
       addition, we note certain line items for the  year  ended  December  31,
       2003  and  for  the six months ended June 30, 2005 do not agree to those
       amounts included  within the audited and unaudited financial statements.
       Please revise.

The  summary financial information  table  has  been  updated  to  reflect  the
restated  values for 2003, 2004, as well as the nine months ended September 30,
2005 information.


Interim Financial Statements

   2. Label each of the interim financial statements as unaudited.  Please also
      note  that  your  interim  financial  statements should include footnotes
      addressing significant transactions for the full interim period, not just
      the most recent three months.

The interim financial statements have been updated  accordingly,  as  have  the
notes to the financial statements.


Independent Auditors' Reports, pages F-3 to F-4

   3. We  do  not  understand  why  your  auditors have not updated their audit
      opinions in light of the material changes  made  to  the  2004  and  2003
      financial  statements.   Additionally,  please  label the revised audited
      financial statements as restated and provide disclosure in your footnotes
      to discuss the nature of the restatement and the  impact on your net loss
      and earnings per share.

The  audit  reports  for  2003  and  2004  have  been  updated to  reflect  the
restatement.  Additionally, the financials have been labeled  restated  as well
as  the required disclosures regarding the nature and impact of the changes  to
the net loss and earnings per share have been disclosed.


Intangible Assets, page F-10

   4. Based  on  the revisions to your 2003 financial statements in response to
      comment 8, we note that your amortization expense increased approximately
      $64,000.  This  amount  is less than the estimate of $111,312 included in
      your previous response to us on August 1, 2005.  Please advise.

When completing the prior response to the Commission's comments, a mathematical
error occurred in the calculation  of  estimated amortization expense for 2003.
Once the Company completed a thorough calculation for the restated 2003 audited
financial  statements,  it was then discovered  that  the  actual  amortization
expense for 2003 was approximately $64,000.


Note 4 - Receivable from Nutek Oil, page F-13

   5. We note your response  to  prior comment 9 and your belief that there was
      no  impairment  to  the  value  of  the  note  receivable  based  on  the
      contractually required calculation used to determine the amount of shares
      issuable.  Please revise to expand  your  disclosures  to  explain  these
      significant  estimates and assumptions, including the basis for the $1.06
      used  for  the conversion  to  support  management's  assessment  of  the
      recoverability  of  the  note similar to the information included in your
      response.  Please make appropriate  disclosure  in your interim financial
      statements and your critical accounting policies within MD&A as well.

The  company  has  expanded  it's  disclosures in the notes  to  the  financial
statements as well as in the MD&A to  discuss the company's position and belief
in the value of the receivable from Nutek Oil.


Convertible Notes Payable and Debentures, pages F-16 to F-17

   6. We note your response to our prior  comment  10.  Based on disclosures in
      your document, we noted that you considered EITF  00-19 in accounting for
      your  convertible  notes.   We  presumed  since  the embedded  conversion
      feature was recorded in permanent equity that were  within  the  scope of
      EITFs  98-5  and  00-27.  However, after further review of the agreements
      filed  in your Form  8-K  dated  November  23,  2004,  it  appears  these
      arrangements may not meet the definition of conventional convertible debt
      in paragraph  4  of  EITF  00-19  since  they  have a feature wherein the
      conversion price is reset if you issue shares at  a  price  less than the
      fixed  conversion price in the note.  As a result, you would be  required
      to analyze  the  conversion feature under paragraphs 12-32 of EITF 00-19.
      In this regard, we  note that your registration rights agreement requires
      you to file a registration  statement  that  is declared effective by the
      SEC within a certain required timeframe or else  you  are required to pay
      liquidated  damages payment equal to 2.0% of the purchase  price  of  the
      notes remaining  unconverted.   It  appears  that  these provisions would
      result in liability classification under EITF 00-19.   If true, you would
      be required to bifurcate the conversion feature from the  debt  host  and
      account  for  the  feature as a derivative liability with changes in fair
      value being recorded in the income statement.  Additionally, we note that
      if you conclude that  this  is  the appropriate accounting, you would not
      account for any beneficial conversion feature under EITFs 98-5 and 00-27.
      Please advise.

The company has reviewed the above disclosures,  authoritative  references, and
after  consultation with our auditors, the office of the Chief Accountant,  and
other consultants  have  made  the  necessary  adjustments  and  disclosures to
correctly  account  for  the  convertible  debt,  as  well  as  the  associated
derivative and warrant liabilities.


   7. In addition, it appears the warrants issued would also be required  to be
      accounted  for  as  derivative  liabilities  under EITF 00-19 since these
      warrants  are  subject to the same registration  rights  agreement  noted
      above.  Please advise.

The company has reviewed  the  above disclosures, authoritative references, and
after consultation with our auditors,  the  office of the Chief Accountant, and
other  consultants  have  made  the necessary adjustments  and  disclosures  to
correctly  account  for  the  convertible  debt,  as  well  as  the  associated
derivative and warrant liabilities.


   8. Please  note that you should  perform  a  through  analysis  of  all  the
      provisions  of  your  convertible  debt  instruments to determine whether
      there are any other provisions that may be  problematic  under paragraphs
      12-32  of  EITF 00-19.  Further, your discussions should be  expanded  to
      include all  of  the significant terms of the convertible debt agreement.
      Clarify if there are any limits on the amount of common stock that may be
      used to repay the  debt  and  any terms that may result in changes to the
      conversion price.

The company has reviewed the above disclosures,  authoritative  references, and
after  consultation with our auditors, the office of the Chief Accountant,  and
other consultants  have  made  the  necessary  adjustments  and  disclosures to
correctly  account  for  the  convertible  debt,  as  well  as  the  associated
derivative and warrant liabilities.


If you have any questions or concerns regarding this comment letter  or our
filing, please do not hesitate to contact the following individual.

Best regards,
Datascension, Inc.

/s/ D. Scott Kincer
- -------------------
Scott Kincer
President / CEO
Tel 714-482-9750
Fax 714-482-9751